Lantern Pharma (LTRN) $21.25 and Provention Bio (PRVB) $13.51 Added to Biotech Six Pack.

The 2021 Biotech Six Pack: Stocks We Expect to Double! These are ideas #3 and #4 for the 'Biotech...
Citius

Wall Street Showing Love. Hepion Pharma (HEPA), Citius Pharma (CTXR) Raise $166 Million.

Hepion (HEPA) Banked $88 Million Yesterday, Citius (CTXR) Banks $78 Million Today. We're beginning to believe (and...
Citius, Biotech Stock Review

Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

The 2021 Biotech Six Pack, Six Stocks We Expect to Double. We're still putting the 2021 list together now,...
Mitesco, Biotech Stock Review, roland rick perry

Short Squeeze Mania.

Citius Pharma (CTXR) Locked and Loaded. Truly Locked and Loaded. Latest $20 Million Round is Biggest News We've Seen...

Make Hay While the Sun Shines. Up 6,400%.

Celcius (CELH) We're Up 6,400%. Alkaline Water (WTER) We're Up 12%.Dicerna (DRNA) We're Up 700%. Ready to Breakout?BioSig (BSGM) We Have...

Adding Brainstorm Therapeutics (BCLI) $4.59 to CoronaVirus Watchlist.

This is a company exploring the use of stem cells for a number of ailments. The lead program is (or was) for...

Heads Up! Big News on Stem Cells & Covid This Weekend.

Gentlemen Start Your Research Engines! Be Fast and Be Early. We Could be Looking at a "Beam Me Up Scotty" Type Vector...
Biotech Stock Review

Video: Okay, You Tested Positive for Corona, Now What?

https://youtu.be/vN30emwcNS4 Professor Roger Seheult,...
dexamethasone, Hepion

Remember President Trump Taking Dexamethasone? Hepion’s (HEPA) CRV431 demonstrated reduced lung inflammation and damage...

Hepion (HEPA) Announces FDA Clearance of IND Application for CRV431 for COVID-19
Aphex

Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement for DermAphex® and...

PITTSFORD, N.Y. , Dec. 16, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization solutions company focused on the development and distribution...

Latest article

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...